there are about 1,000 people who need enhertu.ure too. but for these patients, the dilemma is if — or how — they could get the treatment now. we shouldn't be having to think of moving to scotland or selling our houses or, you know... and i'm really, really annoyed and upset that nice don't feel that my life's important enough to extend, that my contribution to society and to my community, to my friends, my family, that that's not important enough. catherine burns, bbc news. let's speak to claire rowney, who's the chief executive of the charity breast cancer now. thank you so much for being here on the programme. tell me a little more, then, about your reaction to this overall decision.— this overall decision. overall, we are extremely — this overall decision. overall, we are extremely worried _ this overall decision. overall, we are extremely worried about - this overall decision. overall, we are extremely worried about the | are extremely worried about the decision not least because we know that there are thousands of women right

and a drug called enhertu could allow her to do that for longer.urope so far, including scotland. but the health assessment body for england, nice, says it's not value for money. patients in wales and northern ireland won't be able to get it on the nhs either. we have a difficult job at nice. you know, we have to be looking at how to support the nhs to best spend the finite budget that it has. so whilst our decisions can be devastating for patients, we have to think about that broader position of the nhs. but the drug companies believe the problem is nice rating this kind of cancer as only moderately severe. we believe it's a fair price. we believe that we should be getting access for these women with this incurable breast cancer. likejeannie, she knows she will need enhertu but has no idea how to get it. i'm really, really annoyed and upset that nice don't feel that my contribution to society and to my community, to my friends, my family, that that's not important enough. let's speak to kate wills. campaigning to get access welcome to the programm

the health assessment body nice says enhertu isn't value for money, so patients in england, wales andopean countries. the body of the former first minister of scotland, alex salmond, has been returned to scotland. his coffin, draped in the flag of scotland, was met by his family after it was taken off a private plane at aberdeen airport. mr salmond suffered a heart attack in north macedonia on saturday. a date for his funeral hasn't yet been announced. you're live with bbc news. let's get the latest on the race for the white house — we're just over two weeks out from election day and both candidates have turned their attention to michigan today. it is one of seven key battleground us states that could swing to kamala harris or donald trump. the latest polls show the pair neck and neck — and you can see, the numbers here are well within the margin of error. in just the last hour — vice president harris wrapped up a speech in the city of lansing. that speech was focused on labour issues in michigan, one of the biggest manufacturing states in the country. before that, the vice president

it's called enhertu, but they can't get it.ertu through their health services to patients with her2—low breast cancer, including france and germany, as well as places like bulgaria and romania. scotland has given the green light too, but it's the only part of the uk where these patients will get it on the nhs. in england, the health assessment body nice says enhertu is not value for money. wales and northern ireland will follow this guidance too. nice decides which treatments to recommend on the nhs by balancing cost and benefit. severe diseases get extra weight. recently, it's changed its system for doing this. now diseases can be rated as having no severity, no extra weight or highly severe, lots of extra weight, which can help balance out the costs. in this case though, the rating is medium severity, not the maximum weight, and not enough to tip the scales in the favour of these patients. we have a difficultjob at nice. you know, we have to be looking at how to support the nhs to best spend the finite budget that it has. so